Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

A pilot trial evaluating the efficacy of a 10% imidacloprid/2.5% moxidectin spot-on formulation in the treatment of natural nasal capillariosis in dogs.

Veronesi F, Morganti G, Di Cesare A, Schaper R, Traversa D.

Vet Parasitol. 2014 Feb 24;200(1-2):133-8. doi: 10.1016/j.vetpar.2013.11.026. Epub 2013 Dec 3.

2.

Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline infection by Capillaria aerophila.

Traversa D, Di Cesare A, Di Giulio E, Castagna G, Schaper R, Braun G, Lohr B, Pampurini F, Milillo P, Strube K.

Parasitol Res. 2012 Oct;111(4):1793-8. Epub 2012 Jul 11.

5.

First report of Eucoleus boehmi infection in a dog from Portugal.

Alho AM, Mouro S, Pissarra H, Murta A, Lemos M, Gomes L, Lima C, de Carvalho LM.

Parasitol Res. 2016 Apr;115(4):1721-5. doi: 10.1007/s00436-016-4932-6. Epub 2016 Feb 9.

PMID:
26857129
6.

Nasal eucoleosis in a symptomatic dog from Italy.

Veronesi F, Lepri E, Morganti G, Di Palma S, Mechelli L, Moretti A, Traversa D.

Vet Parasitol. 2013 Jul 1;195(1-2):187-91. doi: 10.1016/j.vetpar.2013.01.022. Epub 2013 Feb 1.

PMID:
23433985
7.

Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.

Otranto D, Colella V, Crescenzo G, Solari Basano F, Nazzari R, Capelli G, Petry G, Schaper R, Pollmeier M, Mallia E, Dantas-Torres F, Lia RP.

Vet Parasitol. 2016 Aug 30;227:118-21. doi: 10.1016/j.vetpar.2016.07.035. Epub 2016 Aug 1.

8.

Treatment of E. boehmi infection in a mixed-breed dog using milbemycin oxime.

Conboy G, Stewart T, O'Brien S.

J Am Anim Hosp Assoc. 2013 May-Jun;49(3):204-9. doi: 10.5326/JAAHA-MS-5832. Epub 2013 Mar 27.

PMID:
23535747
9.

Efficacy of a spot on combination containing imidacloprid 10% and moxidectin 1% (Advocate(®)/Advantage(®) Multi, Bayer Animal Health) against Ancylostoma ceylanicum in cats.

Taweethavonsawat P, Chungpivat S, Watanapongchati S, Traub RJ, Schaper R.

Vet Parasitol. 2012 Nov 23;190(1-2):289-93. doi: 10.1016/j.vetpar.2012.05.008. Epub 2012 May 19.

PMID:
22677133
10.

Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.

Fourie JJ, Liebenberg JE, Horak IG, Taenzler J, Heckeroth AR, Frénais R.

Parasit Vectors. 2015 Mar 28;8:187. doi: 10.1186/s13071-015-0775-8.

11.

Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).

Taweethavonsawat P, Chungpivat S, Satranarakun P, Traub RJ, Schaper R.

Parasitol Res. 2010 May;106(6):1499-502. doi: 10.1007/s00436-010-1819-9. Epub 2010 Mar 27.

PMID:
20349196
12.

Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.

Arther RG, Bowman DD, Slone RL, Travis LE.

Parasitol Res. 2005 Oct;97 Suppl 1:S76-80.

PMID:
16228279
13.

Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.

Arther RG, Davis WL, Jacobsen JA, Lewis VA, Settje TL.

Vet Parasitol. 2015 May 30;210(1-2):64-8. doi: 10.1016/j.vetpar.2015.02.022. Epub 2015 Mar 2.

PMID:
25801226
14.

Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.

Petry G, Genchi M, Schmidt H, Schaper R, Lawrenz B, Genchi C.

Parasitol Res. 2015 Aug;114 Suppl 1:S131-44. doi: 10.1007/s00436-015-4519-7.

PMID:
26152414
15.
16.

Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).

Willesen JL, Kristensen AT, Jensen AL, Heine J, Koch J.

Vet Parasitol. 2007 Jul 20;147(3-4):258-64. Epub 2007 Jun 4.

PMID:
17544583
17.

Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.

Paterson TE, Halliwell RE, Fields PJ, Louw ML, Ball G, Louw J, Pinckney R.

Vet Parasitol. 2014 Oct 15;205(3-4):687-96. doi: 10.1016/j.vetpar.2014.08.021. Epub 2014 Sep 4.

18.

Treatment of naturally Notoedres cati-infested cats with a combination of imidacloprid 10 % / moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer).

Hellmann K, Petry G, Capari B, Cvejic D, Krämer F.

Parasitol Res. 2013 Aug;112 Suppl 1:57-66. doi: 10.1007/s00436-013-3281-y.

PMID:
23760872
19.

Efficacy of a single administration of a spot-on solution containing imidacloprid 10%/moxidectin 2.5% in eliminating Dirofilaria repens microfilariae in naturally infected dogs.

Traversa D, Aste G, Di Cesare A, Paoletti B, Di Tommaso M, Di Giulio E, Pampurini F, Tunesi C, Boari A.

Vet Parasitol. 2011 Jun 30;179(1-3):107-12. doi: 10.1016/j.vetpar.2011.02.018. Epub 2011 Mar 1.

PMID:
21435791
20.

Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi).

Le Sueur C, Bour S, Schaper R.

Parasitol Res. 2010 Nov;107(6):1463-9. doi: 10.1007/s00436-010-2022-8. Epub 2010 Aug 13.

Supplemental Content

Support Center